Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
24.01
+0.08 (0.33%)
At close: Apr 17, 2026, 4:00 PM EDT
23.55
-0.46 (-1.92%)
After-hours: Apr 17, 2026, 6:28 PM EDT
Bicara Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$28.00
Upside
+16.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -33.36% | Mar 31, 2026 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +24.95% | Mar 31, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $11 → $16 | Hold | Maintains | $11 → $16 | -33.36% | Mar 31, 2026 |
| Citizens | Citizens | Buy Reiterates $31 | Buy | Reiterates | $31 | +29.11% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $42 | Strong Buy | Maintains | $40 → $42 | +74.93% | Mar 31, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +45.77% | Mar 25, 2026 |
| Citizens | Citizens | Buy Initiates $31 | Buy | Initiates | $31 | +29.11% | Jan 29, 2026 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +24.95% | Jan 13, 2026 |
| BTIG | BTIG | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +16.62% | Jan 8, 2026 |
| Mizuho | Mizuho | Hold Initiates $18 | Hold | Initiates | $18 | -25.03% | Dec 18, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | -54.19% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $40 | Strong Buy | Maintains | $41 → $40 | +66.60% | Aug 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $36 | Buy | Initiates | $36 | +49.94% | Aug 19, 2025 |
| Wells Fargo | Wells Fargo | Sell → Hold Upgrades $8 | Sell → Hold | Upgrades | $8 | -66.68% | May 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $44 → $41 | Strong Buy | Maintains | $44 → $41 | +70.76% | May 16, 2025 |
| Wells Fargo | Wells Fargo | Sell Initiates $8 | Sell | Initiates | $8 | -66.68% | Apr 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.